StonvexLoading…
StonvexCore line items from INV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.44M | $2.06M | $1.23M | $700.00K |
Operating Income | $-27.30M | $-464.70M | $-432.98M | $-403.77M |
Net Income | $-20.80M | $-293.32M | $-255.56M | $-227.22M |
EPS (Diluted) | $-0.27 | $-5.39 | $-4.96 | $-4.60 |
Total Assets | $591.48M | $599.19M | $556.51M | $555.99M |
Total Liabilities | $93.33M | $115.51M | $149.94M | $129.93M |
Cash & Equivalents | $55.37M | $60.45M | $9.06M | $6.96M |
Free Cash Flow OCF − CapEx | $-34.88M | $-82.10M | $-57.70M | $-37.69M |
Shares Outstanding | 80.09M | 67.74M | 56.22M | 55.22M |